Literature DB >> 22626742

Telemonitoring of outpatients with heart failure: a search for the holy grail?

Dirk J van Veldhuisen, Alexander H Maass.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22626742     DOI： 10.1161/CIRCULATIONAHA.112.118141

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

1.  HerzMobil Tirol network: rationale for and design of a collaborative heart failure disease management program in Austria.

Authors:  Andreas Von der Heidt; Elske Ammenwerth; Karl Bauer; Bettina Fetz; Thomas Fluckinger; Andrea Gassner; Willhelm Grander; Walter Gritsch; Immaculata Haffner; Gudrun Henle-Talirz; Stefan Hoschek; Stephan Huter; Peter Kastner; Susanne Krestan; Peter Kufner; Robert Modre-Osprian; Josef Noebl; Momen Radi; Clemens Raffeiner; Stefan Welte; Andreas Wiseman; Gerhard Poelzl
Journal:  Wien Klin Wochenschr       Date:  2014-11-13       Impact factor: 1.704

2.  Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study.

Authors:  Robin Mathews; Eric D Peterson; Emily Honeycutt; Chee Tang Chin; Mark B Effron; Marjorie Zettler; Gregg C Fonarow; Timothy D Henry; Tracy Y Wang
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-06-02

Review 3.  Trials of implantable monitoring devices in heart failure: which design is optimal?

Authors:  William T Abraham; Wendy G Stough; Ileana L Piña; Cecilia Linde; Jeffrey S Borer; Gaetano M De Ferrari; Roxana Mehran; Kenneth M Stein; Alphons Vincent; Jay S Yadav; Stefan D Anker; Faiez Zannad
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

4.  Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.

Authors:  Robin Mathews; Tracy Y Wang; Emily Honeycutt; Timothy D Henry; Marjorie Zettler; Michael Chang; Gregg C Fonarow; Eric D Peterson
Journal:  Am Heart J       Date:  2015-04-02       Impact factor: 4.749

5.  Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality.

Authors:  Robin Mathews; William Wang; Lisa A Kaltenbach; Laine Thomas; Rashmee U Shah; Murtuza Ali; Eric D Peterson; Tracy Y Wang
Journal:  Circulation       Date:  2018-01-31       Impact factor: 29.690

6.  Cost-utility analysis of the EVOLVO study on remote monitoring for heart failure patients with implantable defibrillators: randomized controlled trial.

Authors:  Paolo Zanaboni; Maurizio Landolina; Maurizio Marzegalli; Maurizio Lunati; Giovanni B Perego; Giuseppe Guenzati; Antonio Curnis; Sergio Valsecchi; Francesca Borghetti; Gabriella Borghi; Cristina Masella
Journal:  J Med Internet Res       Date:  2013-05-30       Impact factor: 5.428

7.  The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring.

Authors:  Giuseppe Boriani; Antoine Da Costa; Renato Pietro Ricci; Aurelio Quesada; Stefano Favale; Saverio Iacopino; Francesco Romeo; Arnaldo Risi; Lorenza Mangoni di S Stefano; Xavier Navarro; Mauro Biffi; Massimo Santini; Haran Burri
Journal:  J Med Internet Res       Date:  2013-08-21       Impact factor: 5.428

8.  Effectiveness of a comprehensive interactive eHealth intervention on patient-reported and clinical outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD trial]: study protocol of a national Danish randomised controlled trial.

Authors:  Susanne S Pedersen; Søren J Skovbakke; Uffe K Wiil; Thomas Schmidt; Rene dePont Christensen; Carl J Brandt; Jan Sørensen; Michael Vinther; Charlotte E Larroudé; Thomas M Melchior; Sam Riahi; Kim G E Smolderen; John A Spertus; Jens B Johansen; Jens C Nielsen
Journal:  BMC Cardiovasc Disord       Date:  2018-07-03       Impact factor: 2.298
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.